GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (OTCPK:AKBLF) » Definitions » PB Ratio

AKBLF (Alk-Abello AS) PB Ratio : 5.84 (As of Apr. 05, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Alk-Abello AS PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-05), Alk-Abello AS's share price is $19.90. Alk-Abello AS's Book Value per Share for the quarter that ended in Dec. 2024 was $3.41. Hence, Alk-Abello AS's PB Ratio of today is 5.84.

Good Sign:

Alk-Abello AS stock PB Ratio (=5.91) is close to 1-year low of 5.84.

The historical rank and industry rank for Alk-Abello AS's PB Ratio or its related term are showing as below:

AKBLF' s PB Ratio Range Over the Past 10 Years
Min: 2.25   Med: 4.87   Max: 11.32
Current: 5.91

During the past 13 years, Alk-Abello AS's highest PB Ratio was 11.32. The lowest was 2.25. And the median was 4.87.

AKBLF's PB Ratio is ranked worse than
80.7% of 1285 companies
in the Biotechnology industry
Industry Median: 2.22 vs AKBLF: 5.91

During the past 12 months, Alk-Abello AS's average Book Value Per Share Growth Rate was 20.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 15.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 11.10% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 5.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Alk-Abello AS was 15.30% per year. The lowest was -32.70% per year. And the median was 4.60% per year.

Back to Basics: PB Ratio


Alk-Abello AS PB Ratio Historical Data

The historical data trend for Alk-Abello AS's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello AS PB Ratio Chart

Alk-Abello AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.50 10.64 5.45 4.50 6.56

Alk-Abello AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.50 5.96 6.33 7.75 6.56

Competitive Comparison of Alk-Abello AS's PB Ratio

For the Biotechnology subindustry, Alk-Abello AS's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alk-Abello AS's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alk-Abello AS's PB Ratio distribution charts can be found below:

* The bar in red indicates where Alk-Abello AS's PB Ratio falls into.


;
;

Alk-Abello AS PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Alk-Abello AS's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=19.90/3.407
=5.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Alk-Abello AS  (OTCPK:AKBLF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Alk-Abello AS PB Ratio Related Terms

Thank you for viewing the detailed overview of Alk-Abello AS's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alk-Abello AS Business Description

Traded in Other Exchanges
Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.

Alk-Abello AS Headlines

From GuruFocus

Q2 2021 ALK-Abello A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024

ALK-Abello A/S Annual Shareholders Meeting Transcript

By GuruFocus Research 02-12-2024

Q2 2023 ALK-Abello A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2022 ALK-Abello A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2021 ALK-Abello A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2024 ALK-Abello A/S Earnings Call Transcript

By GuruFocus News 11-18-2024

Q3 2023 ALK-Abello A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q4 2022 ALK-Abello A/S Earnings Call Transcript

By GuruFocus Research 02-12-2024